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ABSTRACT 
Obstructive sleep apnea (OSA) is a serious disease with neurocognitive and cardiovascular sequelae. Various population-
based studies show that 2% of women and 4% of men are affected with symptomatic OSA; however, the prevalence of 
asymptomatic OSA is quite high which affect 20%–30% of the middle-aged population. It can be diagnosed on the basis of 
characteristic history (snoring, daytime sleepiness) and physical examination (increased neck circumference); nevertheless, 
overnight polysomnography is the gold standard to confirm the presence of the disorder. Many treatment modalities have been 
evolved to address the disease which include lifestyle modification; medical therapy; CPAP; oral appliances; and surgical 
correction. Although the initial choice of treatment is CPAP in most of the patients, it can be tailored according to Apnea-
hypopnea index (AHI) and the need of the individual patient. In addition, surgical interventions are the preferred option in 
certain cases which not only provide a quick cure of OSA but also correct many facial anomalies.  
Keywords:- Obstructive sleep apnea; CPAP; Klearway Appliance; Uvulopalatopharyngoplasty; Maxillomandibular 
advancement 
 
 
bstructive sleep apnea (OSA) is a disease of 
increasing importance due to its alarming cardiac 
and neurocognitive consequences, characterized 
by complete cessation or occurrence of shallow or 
infrequent breathing during sleep for seconds to minutes 
[1-6]. According to various studies, the prevalence of OSA 
among middle-aged men ranges from 1–4%; however; in 
the same age range women, its occurrence is only1.2–2.5% 
[7-11]. Usually, the airway patency is preserved by 
activation of the pharyngeal dilator muscle (e.g. 
genioglossus) and by an increase in lung volume, which 
tend to keep the airway open by longitudinal traction [12-
16]. However, variables tend to promote pharyngeal 
collapse include negative pressure within the airway (e.g. 
during inspiration) and positive pressure outside the airway 
(e.g. fat deposition around the neck, small mandible). As a 
result, dilating forces (muscle activation) have a complex 
interaction with collapsing forces (anatomy, airway  
 
negative pressure) [17-21]. Thus, apneas are more likely to 
occur when obesity, retrognathia or a supine posture is 
present [22]. The site at which the obstruction occurs may 
vary, usually; the posterior aspect of the tongue comes to 
rest on the posterior pharyngeal wall [22-23]. 
OSA has many consequences like impairment in quality of 
life, cognitive functioning, and most commonly excessive 
daytime somnolence (EDS) which predispose the patient to 
traffic or occupational accidents. In addition, untreated 
OSA patient is under risk of developing systemic 
hypertension,  polycythemia, cardiovascular events, and 
cerebrovascular accidents [22-23]. Diagnostic evaluation 
of OSA includes a complete history and physical 
examination, fiberoptic endoscopy, radiologic evaluation, 
and polysomnography; however, the latter one is 
considered a gold standard diagnostic test for it [24]. (In 
our previous article; Obstructive Sleep Apnea: Prevalence 
O 
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and Diagnosis- A Review, prevalence, and diagnosis of 
OSA have been discussed in detail) [22]. Various medical 
and surgical treatment modalities have been evolved to 
treat the OSA for the last few decades; however; every 
treatment has its own advantages and limitations. This 
review provides an overview of available options for 
treatment of this serious disorder. 
 
CONSERVATIVE/MEDICAL TREATMENT 
The treatment of obese patients with moderate OSA must 
initially start with some of the lifestyle changes. Some of 
these modifications include exercise, weight loss, [25-27] 
decreased alcohol consumption, smoking cessation, altered 
sleeping position, and nasal continuous positive airway 
pressure [28-29]. There are certain medications which 
should be avoided as those drugs may worsen OSA such as 
alcohol which reduces the tone of the genioglossus and 
increases collapsibility of upper airway [30]. Then, there is 
opioids which decrease the rate and depth of respiration, 
induce chest and abdominal wall rigidity, reduce upper 
airway patency and blunt respiratory response to carbon 
dioxide and hypoxia. Also, other central nervous system 
depressants like benzodiazepines cause reduced upper 
airway muscle tone and decrease ventilatory response to 
hypoxia, thus potentially increasing the AHI and 
prolonging apnea events. Recently, a Cochrane review 
found no worsening of OSA with most of the hypnotic and 
sedative drugs; however; decreases in minimum overnight 
SpO2 was observed. Testosterone replacement therapy 
(increases Apnea Hypopnea Index and prolonged 
hypoxemia time) has also been suggested to worsen OSA.  
The medication which causes weight gain should also be 
avoided like atypical antipsychotics, antidepressants, 
anticonvulsants, etc [31]. In addition, there are several 
endocrine conditions that may present as OSA or may 
contribute to OSA. Thus, all initial evaluations of patients 
should include consideration of whether the patient has 
clinical signs and symptoms of hypothyroidism, 
acromegaly or Cushing’s syndrome. Among these 
conditions, hypothyroidism is the most common (2% of 
adults), and its presentation may overlap with OSA 
symptoms: fatigue, weight gain, myalgias, memory loss, 
decreased libido, and depressed mood. Symptoms of OSA 
may improve by the treatment of the underlying endocrine 
disorder. The tricyclic antidepressant Protriptyline is the 
most effective drug studied in the treatment of OSA. 
Protriptyline produces its beneficial effect by stimulation 
of upper airway muscle tone and by decreasing the 
percentage of time spent in REM sleep, thereby reducing 
the more severe REM-related apneas. 
Another remarkable drug is Modafinil, [32,33] a non-
amphetamine CNS stimulant, which is used to reduce the 
daytime somnolence and increase alertness, but it is 
essential to understand that Modafinil cannot be used as a 
substitute for CPAP or an oral appliance. Additionally, 
Acetazolamide, a carbonic anhydrase inhibitor stimulates 
respiration by producing metabolic acidosis, thus, reduce 
the number of apneas and decrease the severity of oxygen 
desaturations in patients with OSA. Some patients with 
OSA benefit from the respiratory stimulant effect of 
progesterone, especially those with the obesity-
hypoventilation syndrome. Recently some studies have 
found that Bariatric surgeries lead to 
resolution/improvement of the patient's OSA, as measured 
by AHI.  
CONTINUOUS POSITIVE AIRWAY PRESSURE 
(CPAP) 
Currently, CPAP is the most successful non-surgical 
treatment of OSA. The nasal CPAP is administered by 
means of a tight-fitting mask (Figure 1) while the patient is 
asleep.  
 
Figure 1: CPAP Machine & Mask 
A CPAP of 7 to 15 cm of water acts as a pneumatic splint 
of the upper airway and prevents the passive collapse of 
soft tissues during respiration while sleeping. Stimulation 
of mechanoreceptors of the genioglossus muscle leading to 
increased airway tone has also been suggested as a 
mechanism of action. By this means, it provides 
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unobstructed breathing, (Figure 2 & 3). Before CPAP 
intermittent episodes of absent air flow that improve 
markedly on  application of CPAP in flow tracings. 
Thereby reducing apneas and hypopneas; therefore, it has 
been proved to be effective in reducing day time sleepiness 
levels in OSA patients [34-36]. Sullivan et al firstly 
reported the successful treatment of sleep apnea with nasal 
CPAP in 1981.  
 
Figure 2: Polysomnography before CPAP 
 
Figure 3: Polysomnography after CPAP 
Recently, bi-level positive airway pressure (Bi-PAP) 
systems that allow independent regulation of inspiratory 
and expiratory pressures and the newest modification in 
CPAP systems, Auto-CPAP, have been used to more 
effectively treat obstructive sleep apnea and increase 
tolerance and compliance. Noticeably, Auto-CPAP units 
adjust the CPAP throughout the night rather than 
delivering one fixed pressure. In addition, the newer 
models provide masks of adjustable size for patient 
comfort. Although CPAP therapy has been proved very 
successful, patient’s compliance is low. According to one 
study compliance rates at 12 months have been reported as 
low as 54%. On the other hand, disadvantages of CPAP 
are nasal dryness, congestion, sore throat, dryness of the 
skin, eyes, and noise [37-40]. 
Recently, Stephen A. Marsh has invented a micro CPAP 
device and claimed it as a world’s first mask-less, hoseless, 
cordless micro-CPAP device; named Airing. Although he 
claims that this device having a revolutionary design that 
will work like any other CPAP machine and patients will 
not have to deal with cumbersome, uncomfortable masks, 
it needs FDA approval and clinical studies first, to be 
marketed in the future [41]. 
ORAL APPLIANCES 
The use of a variety of prosthetic devices is another 
approach to treatment. The American Sleep Disorders 
Association recommends that oral appliances may be used 
in patients with primary snoring, mild obstructive sleep 
apnea, or in patients with moderate to severe obstructive 
sleep apnea who refuse or are intolerant of nasal 
continuous positive airway pressure. These devices help to 
maintain an unobstructed airway by repositioning of the 
lower jaw and stabilization of the tongue [41-44]. There 
are various oral appliances available in the market such as 
tongue-retaining device, Klearway appliance (Figure 4), 
Herbst appliance, Elastic Mandibular Advancement, 
Elastomeric Sleep Appliance, Equalizer Airway Device 
etc. [45,46].  
 
Figure 4: Klearway appliance 
Side effects of oral appliance therapy are excessive 
salivation, xerostomia, soft tissue irritations, transient 
discomfort of the teeth and temporomandibular joint 
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(TMJ), minor occlusal changes, and stiffness or pain of 
masticatory muscles; however, literature shows few cases 
with loosening of teeth during long term appliance therapy 
[47-49]. 
SURGICAL TREATMENT  
Numerous studies show that over half the patients will not 
follow the conservative treatment for an extended period 
or patients do not obtain sufficient relief from their snoring 
with conservative methods and look for surgical modalities 
to correct their problem. Currently, the procedures used in 
the surgical treatment of obstructive sleep apnea include 
tracheostomy, nasal surgery, Uvulopalatopharyngoplasty, 
and several orthognathic surgical procedures. 
Tracheostomy was the first efficacious surgical procedure 
for treating obstructive sleep apnea, firstly done 
successfully by Kuhlo et al in 1969. It is almost 100% 
curative in relieving the signs and symptoms of obstructive 
sleep apnea. But lifelong tracheostomy causes social and 
other medical problems so having least acceptance and 
should be used as the last option [50].  However, surgery is 
considered a quick cure of OSA, it has its own indications 
and limitations as well. 
SURGICAL INDICATIONS 
 Apnea-hypopnea index (AHI) ≥ 20 events/hr of 
sleep 
 Oxygen desaturation <90% 
 Esophageal pressure (Pes) more negative than -10 
cm of H2O 
 Cardiovascular derangements (arrhythmia, 
hypertension) 
 Neurobehavioral symptoms [excessive daytime 
somnolence (EDS)] 
 Failure of medical management 
 Anatomical sites of obstruction (nose, palate, 
tongue base) 
(Surgery may be indicated with an AHI<20 if 
accompanied by excessive daytime fatigue). In 1993, a 
surgical protocol for dynamic upper airway reconstruction 
in the treatment of obstructive sleep apnea syndrome was 
presented by Riley and Powell [51]. On the basis of their 
study on 239 cases, they presented two-phase protocol. 
Phase I, which included a conservative approach and 
involved Uvulopalatopharyngoplasty and/or mandibular 
osteotomy with genioglossus advancement-hyoid 
myotomy and suspension. Polysomnography was repeated 
at 6 months, and patients with unsuccessful surgical results 
were offered phase two treatment which included 
maxillary-mandibular advancement. 
POWELL–RILEY OR STANFORD PROTOCOL 
SURGICAL PROCEDURES 
Phase I 
 Nasal surgery (Septoplasty, turbinate reduction, 
nasal valve grafting) 
 Tonsillectomy 
 Uvulopalatopharyngoplasty (UPPP) or 
Uvulopalatal flap (UPF) 
 Mandibular osteotomy with genioglossus 
advancement 
 Hyoid myotomy and suspension 
 Temperature-controlled radiofrequency (TCRF)—
turbinates, palate, tongue base 
Phase II 
 Maxillomandibular advancement osteotomy 
(MMO) 
 Temperature-controlled radiofrequency (TCRF)—
tongue base 
NASAL SURGERIES 
A patent nasal airway is essential for normal respiration 
and sleep.  Any obstruction can increase airway resistance 
and result in mouth breathing. Opening of the mouth 
rotates the mandible posteriorly, which in turn allows the 
tongue to prolapse into the posterior airway space (PAS) 
and narrow the hypopharyngeal airway. Nasal obstruction 
can occur due to septal deviations, incompetent nasal 
valves, or enlarged turbinates. Various techniques 
(Septoplasty, alar grafting, and turbinate reduction) exist to 
treat nasal obstruction [52]. 
THE PILLAR PROCEDURE (SOFT PALATE 
IMPLANTS) 
The Pillar procedure is a minimally invasive approach that 
can relieve habitual snoring and mild to moderate cases of 
sleep apnea as well. It involves the placement of three to 
five polyester rods into the soft palate.  Each implant 
Ahmad & Chopra                                                                                                       A review of treatment of OSA 
Vol 8| Issue 2| Apr–Jun 2019                                                                                                             J Orofac Res 20 
measures 18 mm in length and 1.5 mm in diameter. The 
rods initiate an inflammatory response of the surrounding 
soft tissues that results in stiffening of the soft palate. 
Subsequently, the stiffer soft palate is less likely to make 
contact with the back wall of the pharynx during deep 
stages of sleep as the muscles relax, thereby reducing 
snoring and apnea. Additionally, this procedure can be 
done under local anesthesia in the clinic [53] (Figure 5) 
. 
Figure 5: Placement of implant in the Soft Palate 
UVULOPALATOPHARYNGOPLASTY 
Uvulopalatopharyngoplasty (UPPP) is a surgical procedure 
which is used to remove excess tissue in the upper airway 
to widen the posterior airway space. This surgical 
intervention is mainly focused on the shortening of the 
uvula, removal of a portion of soft palate tonsils, adenoid 
and part of pharynx [54-56] (Figure 6).  
 
Figure 6: Before and after UPPP 
Type of UPPP: Traditional UPPP; Laser-Assisted UPPP; 
Temperature-controlled radiofrequency (TCRF) UPPP. A 
long term side effect of UPPP is change in the pattern of 
voice and worsening of GERD. 
TONGUE PROCEDURE 
As the tongue base is one of the most common sites of 
obstruction in OSA, reduction of tongue mass, especially 
it's base resection; has been proved an effective method to 
control the disorder. Djuperlandet al [56] (1992) and 
Midjejeig (1992) described an operation termed 
uvulopalatopharyngoglossoplasty (UPPGP) which 
included modified Uvulopalatopharyngoplasty (UPPP) 
with limited resection of the tongue base. In another study, 
Fugita et al. [57] performed midline glossectomy (Figure7) 
in 12 patients to create an enlarged hypo-pharyngeal 
airspace using the carbon dioxide laser, and they found 
promising results.  
 
Figure 7: Midline Glossectomy  
While Chabolle et al. (1999) combined tongue base 
reduction with hyoepiglossoplasty in a small study of 10 
patients and reported considerable improvement. The intra-
operative complications; however, that may occur in such 
procedures are those of any surgical intervention in the 
oral and pharyngeal cavity; namely that of hemorrhage and 
airway obstruction. Moreover; tongue numbness, transient 
changes in taste, dysphagia, and infection may also occur 
postoperatively [58-59]. 
MANDIBULAR OSTEOTOMY WITH 
GENIOGLOSSUS ADVANCEMENT 
Genioglossus advancement is indicated for patients with 
documented hypo-pharyngeal obstruction (Fujita type II-
III). It may be used as a sole or in combination with other 
surgical procedures. 
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HYOID MYOTOMY AND SUSPENSION 
The rationale for hyoid myotomy and suspension is to 
alleviate hypopharyngeal obstruction by advancing the 
hyoid complex in an anterior direction. Originally, this 
surgery involved suspending the hyoid to the mandible 
with fascia lata. However, this required additional 
incisions and dissection to harvest the fascia lata and  
However, this required additional incisions and dissection 
to harvest the fascia lata and expose the mandible. To 
reduce the extent of surgery, the technique has been 
modified to suspend the hyoid bone to the superior border 
of the thyroid cartilage. 
MAXILLOMANDIBULAR ADVANCEMENTS 
Combined advancement of the maxilla and mandible with 
or without hyoid suspension is the most recent and 
efficacious surgical procedure for the treatment of 
obstructive sleep apnea, and it is considered as Phase II of 
Powell Riley protocol. Kuo et al., and Bear and Priest were 
the first to report the treatment of obstructive sleep 
disorder with skeletal surgery; the success rate is 65-100% 
[60-63]. MMO enlarges both the hypo-pharyngeal and 
pharyngeal airway in anteroposterior and lateral 
dimensions by expanding the skeletal facial framework 
(Figure 8).  
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Figure 8:Mandibular Advancement  
It is the only surgery in the protocol that physically creates 
more space for the tongue in the oral cavity. In addition, it 
exerts further tension on the velopharyngeal and 
Suprahyoid musculature to prevent their posterior collapse. 
Drawbacks include complications like intraoperative 
hemorrhage, obstructive airway or post-operative TMJ 
dysfunction and damage to inferior alveolar neurovascular 
bundle [64-65].  
RECOMMENDATIONS 
 Management of OSA requires long-term, 
multidisciplinary care. It should start with patient 
education. Most importantly, patients should be made 
aware of the consequences of untreated OSA, 
especially day time sleepiness and road traffic 
accidents. 
 Lifestyle and behavior modifications are indicated for 
most OSA patients that include reducing weight, 
physical exercising, avoiding alcohol and certain 
medications. 
 Mild to moderate OSA, we suggest CPAP as initial 
therapy. However, a patient who anticipates problems 
with CPAP adherence, an oral appliance can be a 
reasonable alternative as first-line therapy. 
 Surgical therapy is an option for the patients in whom 
CPAP or an oral appliance is either declined, not an 
option, or ineffective. Nevertheless, patients whose 
OSA is due to a surgically correctable obstructing 
lesion, surgical intervention can be first-line therapy.  
CONCLUSION 
In this review, various treatment measures for OSA: 
conservative and surgical have been discussed; however, 
both the modalities have their own pros and cons. 
Inevitably, conservative methods are considered the first 
line of therapy for OSA, and CPAP has been proved as the 
most successful conservative modality, though, poor 
patient compliance is a critical issue in these methods. On 
the other hand, surgical interventions which provide fast 
relief from snoring and apneas; include different type of 
procedures consisting of intraoperative and postoperative 
complications like any other surgery [51, 52, 54]. Kryger 
et al [66] and Osman et al [67] also recommended the 
same guidelines for OSA patients. However, correct 
diagnosis of the disease and detection of the site of 
obstruction are equally important before starting any 
therapy, and treatment can be tailored according to the 
individual need. This review is an attempt to overview of 
different methods to treat patients of OSA; nevertheless, 
detailed descriptions of the procedures are beyond the 
scope of this article. To conclude, OSA is a serious 
disorder with highly detrimental cardiac and 
neurocognitive effects which needs early and 
multispecialty treatment approach. Thus, various specialty 
especially physician, dentist, and surgeon should work 
together with good communication to treat the patient of 
OSA.   
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